Pfizer Inc. (PFE.NE)

CAD 10.28

(1.08%)

EBITDA Summary of Pfizer Inc.

Pfizer Inc.'s latest annual EBITDA in 2023 was 9.55 Billion USD , down -74.39% from previous year.
Pfizer Inc.'s latest quarterly EBITDA in 2024 Q2 was 4.39 Billion CAD , down -59.54% from previous quarter.
Pfizer Inc. reported an annual EBITDA of 41.03 Billion USD in 2022, up 70.29% from previous year.
Pfizer Inc. reported an annual EBITDA of 30.79 Billion USD in 2021, up 76.43% from previous year.
Pfizer Inc. reported a quarterly EBITDA of 4.39 Billion CAD for 2024 Q2, down -59.54% from previous quarter.
Pfizer Inc. reported a quarterly EBITDA of 104.87 Million USD for 2023 Q4, up 104.59% from previous quarter.

Annual EBITDA Chart of Pfizer Inc. (2023 - 2016)

Historical Annual EBITDA of Pfizer Inc. (2023 - 2016)

Year	EBITDA	EBITDA Growth
2023	9.55 Billion USD	-74.39%
2022	41.03 Billion USD	70.29%
2021	30.79 Billion USD	76.43%
2020	13.26 Billion USD	4.58%
2019	18.64 Billion CAD	-37.15%
2018	28.09 Billion CAD	4.75%
2017	19.84 Billion CAD	1.05%
2016	26.53 Billion CAD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	8.48 Billion USD	435.8%
2024 Q2	4.39 Billion CAD	-59.54%
2023 Q4	104.87 Million USD	104.59%
2023 Q1	10.64 Billion USD	14.16%
2023 FY	- USD	-74.39%
2023 Q2	4.9 Billion USD	-53.93%
2023 Q3	-2.28 Billion USD	-146.64%
2022 Q3	14.21 Billion CAD	-21.18%
2022 FY	- USD	70.29%
2022 Q4	9.32 Billion CAD	-34.41%
2022 Q2	18.03 Billion CAD	26.77%
2022 Q1	14.22 Billion CAD	147.61%
2021 Q4	5.74 Billion CAD	0.0%
2021 FY	- USD	76.43%
2020 FY	- USD	4.58%
2019 FY	- CAD	-37.15%
2018 FY	- CAD	4.75%
2017 FY	- CAD	1.05%
2016 FY	- CAD	0.0%

Peer EBITDA Comparison of Pfizer Inc.

Name	EBITDA	EBITDA Difference